Concepedia

Michael J. Robarge

MJ

9

Publications

359

Citations

9

H-Index

1999

Active since

Affiliations

National Institute on Drug Abuse(Current)

Athersys (United States)

National Institutes of Health

Michael J. Robarge is an author at National Institute on Drug Abuse specializing in drug discovery, pharmacotherapy, and medicine.

Top concepts

Publications per year

1999–2010

9

Publications

9

Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D<sub>3</sub>Receptor Subtype

Michael J. Robarge, Stephen M. Husbands, Andrzej Kieltyka et al. · Journal of Medicinal Chemistry · 2001 · 85 citations · Full text

N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists

Amy Hauck Newman, Jianjing Cao, Christina Bennett et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 59 citations · Full text

, , +5

3-Indolyl sultams as selective CRTh2 antagonists

L. Nathan Tumey, Michael J. Robarge, Elizabeth Gleason et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 48 citations · Full text

, , +5

Highly Selective Chiral N-Substituted 3α-[Bis(4‘-fluorophenyl)methoxy]tropane Analogues for the Dopamine Transporter:  Synthesis and Comparative Molecular Field Analysis

Michael J. Robarge, Gregory E. Agoston, Sari Izenwasser et al. · Journal of Medicinal Chemistry · 2000 · 45 citations · Full text

CoMFA Study of Novel Phenyl Ring-Substituted 3α-(Diphenylmethoxy)tropane Analogues at the Dopamine Transporter

Amy Hauck Newman, Sari Izenwasser, Michael J. Robarge et al. · Journal of Medicinal Chemistry · 1999 · 33 citations · Full text

Rows per page

1–5 of 9